Deprecated: Creation of dynamic property PL_VBP_License::$version is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/license-page.php on line 92

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the listeo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170

Deprecated: Creation of dynamic property Vidbg_WPBakery::$vc_row_atts is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/inc/classes/vidbg_wpbakery.php on line 49
Learn - Page 38 of 95 - HealingMaps

Magic Mushrooms Court Ruling Could Reshape India’s Drug Laws: “It’s A Natural Fungus”

This decision has significant legal implications, particularly for future cases involving psychedelic substances like magic mushrooms.

Read More

Watch Bill Gates Talk About Taking LSD

Bill Gates has long been called a square, but it turns out he actually took LSD in his youth (like Steve Jobs) - but doesn't recommend it.

Read More

The Cost of Becoming a Psilocybin Facilitator in Oregon

The cost of becoming a psilocybin facilitator in Oregon may be a bit more expensive than you think. Is it worth it?

Read More

The Power of Group Dynamics in Psychedelic Therapy

A growing body of research suggests that psychedelics can do more than just alter perception—they can deepen human connections.

Read More

UVA Receives $9.3 Million Grant to Study Ketamine’s Potential in Preventing Epileptic Seizures

(UVA) has received a $9.3 million grant from the NIH to study ketamine as a potential treatment for status epilepticus.

Read More

FDA Approves Standalone Use of Johnson & Johnson’s Spravato for Depression

The FDA has expanded the approval of Johnson & Johnson's nasal spray, Spravato, for standalone use in treating major depressive disorder.

Read More

Beckley Psytech Reports Positive Results for Alcohol Use Disorder Treatment

Beckley Psytech has announced encouraging results from a Phase IIa clinical trial for alcohol use disorder.

Read More

Low-Dose Ketamine Improves Brain Network Integrity in Depression Patients

In this study, low-dose ketamine led to significant improvements in mood and cognition within just a few hours of treatment.

Read More

Colorado Explores Synthetic Psilocybin for Mental Health Treatment

Colorado looks at synthetic psilocybin as the next potential treatment option in a wide range of mental health issues.

Read More

VA Official Praises RFK Jr.’s Psychedelics Stance, Offering Hope for Reform

A Veteran's Affairs official is hopeful that RFK Jr's psychedelics stance could bring reform and potential FDA approved treatments.

Read More